These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8608957)

  • 1. Murine colon carcinoma cells engineered to produce human interleukin-2 induce tumor-specific anti-tumor response.
    Gunji Y; Tagawa M; Matsubara H; Takenaga K; Shimada H; Kondo F; Suzuki T; Nakajima K; Aoki T; Asano T; Ochiai T; Isono K; Kageyama H; Nakamura Y; Sakiyama S
    Int J Cancer; 1996 Mar; 66(1):135-9. PubMed ID: 8608957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of T cell dependent acquired immunity in syngeneic mice by the combined expression of interleukin-4 and granulocyte macrophage-colony stimulating factor gene in murine colon carcinoma cells.
    Tasaki K; Gunji Y; Matsubara H; Takenaga K; Suzuki T; Asano T; Ochiai T; Isono K; Kouzu T; Sakiyama S; Tagawa M
    Anticancer Res; 1998; 18(3A):1453-6. PubMed ID: 9673355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of IL-27 in murine carcinoma cells produces antitumor effects and induces protective immunity in inoculated host animals.
    Chiyo M; Shimozato O; Yu L; Kawamura K; Iizasa T; Fujisawa T; Tagawa M
    Int J Cancer; 2005 Jun; 115(3):437-42. PubMed ID: 15688376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretion of interleukin-10 from murine colon carcinoma cells suppresses systemic antitumor immunity and impairs protective immunity induced against the tumors.
    Kawamura K; Bahar R; Natsume W; Sakiyama S; Tagawa M
    Cancer Gene Ther; 2002 Jan; 9(1):109-15. PubMed ID: 11916240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4 T cells inhibit in vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genes.
    Martinotti A; Stoppacciaro A; Vagliani M; Melani C; Spreafico F; Wysocka M; Parmiani G; Trinchieri G; Colombo MP
    Eur J Immunol; 1995 Jan; 25(1):137-46. PubMed ID: 7843224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor cells engineered to express interleukin-6 exhibit a reduced tumorigenicity depending on the tumor cell model.
    Ledda MF; Adris S; Bravo AI; Bover L; Carbone C; Paleolog E; Mordoh J; Chernajovsky Y; Podhajcer OL
    Cell Mol Biol (Noisy-le-grand); 1996 Jul; 42(5):769-78. PubMed ID: 8832108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inoculation of human interleukin-17 gene-transfected Meth-A fibrosarcoma cells induces T cell-dependent tumor-specific immunity in mice.
    Hirahara N; Nio Y; Sasaki S; Minari Y; Takamura M; Iguchi C; Dong M; Yamasawa K; Tamura K
    Oncology; 2001; 61(1):79-89. PubMed ID: 11474253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of peritoneal dissemination of colon carcinoma in syngeneic mice immunized with interleukin-2-producing cells.
    Gunji Y; Tagawa M; Matsubara H; Takenaga K; Sugaya M; Tasaki K; Maeda T; Kondo F; Nakajima K; Suzuki T; Asano T; Ochiai T; Isono K; Sakiyama S
    Cancer Lett; 1996 Dec; 109(1-2):171-6. PubMed ID: 9020917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of systemic immunity by expression of interleukin-23 in murine colon carcinoma cells.
    Wang YQ; Ugai S; Shimozato O; Yu L; Kawamura K; Yamamoto H; Yamaguchi T; Saisho H; Tagawa M
    Int J Cancer; 2003 Jul; 105(6):820-4. PubMed ID: 12767068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transduction of murine colon carcinoma cells with interleukin-15 gene induces antitumor effects in immunocompetent and immunocompromised hosts.
    Tasaki K; Yoshida Y; Miyauchi M; Maeda T; Takenaga K; Kouzu T; Asano T; Ochiai T; Sakiyamna S; Tagawa M
    Cancer Gene Ther; 2000 Feb; 7(2):255-61. PubMed ID: 10770634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the interleukin-21 gene in murine colon carcinoma cells generates systemic immunity in the inoculated hosts.
    Ugai S; Shimozato O; Kawamura K; Wang YQ; Yamaguchi T; Saisho H; Sakiyama S; Tagawa M
    Cancer Gene Ther; 2003 Mar; 10(3):187-92. PubMed ID: 12637939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful immunogene therapy using colon cancer cells (colon 26) transfected with plasmid vector containing mature interleukin-18 cDNA and the Igkappa leader sequence.
    Yoshimura K; Hazama S; Iizuka N; Yoshino S; Yamamoto K; Muraguchi M; Ohmoto Y; Noma T; Oka M
    Cancer Gene Ther; 2001 Jan; 8(1):9-16. PubMed ID: 11219497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity and immune enhancement of murine interleukin-23 expressed in murine colon carcinoma cells.
    Shan BE; Hao JS; Li QX; Tagawa M
    Cell Mol Immunol; 2006 Feb; 3(1):47-52. PubMed ID: 16549049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective immunity is induced in murine colon carcinoma cells by the expression of interleukin-12 or interleukin-18, which activate type 1 helper T cells.
    Tasaki K; Yoshida Y; Maeda T; Miyauchi M; Kawamura K; Takenaga K; Yamamoto H; Kouzu T; Asano T; Ochiai T; Sakiyama S; Tagawa M
    Cancer Gene Ther; 2000 Feb; 7(2):247-54. PubMed ID: 10770633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of persistent tumor-protective immunity in mice cured of established colon carcinoma metastases.
    Xiang R; Lode HN; Dreier T; Gillies SD; Reisfeld RA
    Cancer Res; 1998 Sep; 58(17):3918-25. PubMed ID: 9731503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mice vaccination with interleukin 12-transduced colon cancer cells potentiates rejection of syngeneic non-organ-related tumor cells.
    Adris S; Chuluyan E; Bravo A; Berenstein M; Klein S; Jasnis M; Carbone C; Chernajovsky Y; Podhajcer OL
    Cancer Res; 2000 Dec; 60(23):6696-703. PubMed ID: 11118055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different tumours, transduced with different cytokine genes as G-CSF and IL-2, show inhibition of tumour take through neutrophil activation but differ in T cell functions.
    Stoppacciaro A; Forni G; Colombo MP
    Folia Biol (Praha); 1994; 40(1-2):89-99. PubMed ID: 7525363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of peritoneal dissemination of murine colon carcinoma cells by administrating retrovirus harboring IL-2 gene.
    Gunji Y; Tasaki K; Tagawa M; Matsubara H; Takenaga K; Suzuki T; Asano T; Ochiai T; Isono K; Sakiyama S
    Cancer Gene Ther; 1998; 5(6):339-43. PubMed ID: 9917087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of experimental lung metastasis of murine colon carcinoma cells depends on the amount of interleukin-2 secreted from the transduced cells.
    Tasaki K; Tagawa M; Gunji Y; Matsubara H; Takenaga K; Muramatsu M; Fujimura S; Suzuki T; Asano T; Ochiai T; Isono K; Kouzu T; Sakiyama S
    Anticancer Res; 1998; 18(2A):813-7. PubMed ID: 9615724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-tumor immunity induced by in vivo adenovirus vector-mediated expression of CD40 ligand in tumor cells.
    Kikuchi T; Crystal RG
    Hum Gene Ther; 1999 May; 10(8):1375-87. PubMed ID: 10365667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.